Envoy Medical (COCH) Competitors $1.44 -0.02 (-1.03%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$1.46 +0.02 (+1.38%) As of 08/1/2025 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock COCH vs. LUNG, INFU, BSGM, OBIO, LUCD, AVR, ICAD, ZJYL, FONR, and MBOTShould you be buying Envoy Medical stock or one of its competitors? The main competitors of Envoy Medical include Pulmonx (LUNG), InfuSystem (INFU), Biosig Technologies (BSGM), Orchestra BioMed (OBIO), Lucid Diagnostics (LUCD), Anteris Technologies Global (AVR), icad (ICAD), Jin Medical International (ZJYL), Fonar (FONR), and Microbot Medical (MBOT). These companies are all part of the "medical equipment" industry. Envoy Medical vs. Its Competitors Pulmonx InfuSystem Biosig Technologies Orchestra BioMed Lucid Diagnostics Anteris Technologies Global icad Jin Medical International Fonar Microbot Medical Pulmonx (NASDAQ:LUNG) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations. Do insiders and institutionals believe in LUNG or COCH? 91.0% of Pulmonx shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 6.8% of Pulmonx shares are held by insiders. Comparatively, 58.9% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings & valuation, LUNG or COCH? Envoy Medical has lower revenue, but higher earnings than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPulmonx$83.79M0.77-$56.39M-$1.43-1.13Envoy Medical$220K140.10-$20.80M-$1.38-1.05 Does the media prefer LUNG or COCH? In the previous week, Pulmonx had 19 more articles in the media than Envoy Medical. MarketBeat recorded 20 mentions for Pulmonx and 1 mentions for Envoy Medical. Pulmonx's average media sentiment score of 0.01 beat Envoy Medical's score of -1.33 indicating that Pulmonx is being referred to more favorably in the media. Company Overall Sentiment Pulmonx Neutral Envoy Medical Negative Is LUNG or COCH more profitable? Pulmonx has a net margin of -62.88% compared to Envoy Medical's net margin of -10,961.26%. Envoy Medical's return on equity of 0.00% beat Pulmonx's return on equity.Company Net Margins Return on Equity Return on Assets Pulmonx-62.88% -66.36% -35.51% Envoy Medical -10,961.26%N/A -233.08% Do analysts rate LUNG or COCH? Pulmonx presently has a consensus price target of $7.66, indicating a potential upside of 376.04%. Envoy Medical has a consensus price target of $9.25, indicating a potential upside of 540.14%. Given Envoy Medical's stronger consensus rating and higher probable upside, analysts plainly believe Envoy Medical is more favorable than Pulmonx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulmonx 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.56Envoy Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, LUNG or COCH? Pulmonx has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.21, suggesting that its stock price is 121% more volatile than the S&P 500. SummaryEnvoy Medical beats Pulmonx on 9 of the 16 factors compared between the two stocks. Get Envoy Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for COCH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding COCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COCH vs. The Competition Export to ExcelMetricEnvoy MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$31.14M$6.77B$5.48B$9.51BDividend YieldN/A1.32%4.73%4.09%P/E Ratio-1.0120.9428.6723.80Price / Sales140.1054.14373.9066.58Price / CashN/A20.5035.4557.96Price / Book-1.644.468.275.55Net Income-$20.80M$174.54M$3.24B$259.03M7 Day Performance-7.37%-5.27%-3.69%-4.59%1 Month Performance-3.67%-3.94%4.33%4.46%1 Year Performance-44.21%8.26%25.95%18.03% Envoy Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COCHEnvoy Medical1.9376 of 5 stars$1.45-1.0%$9.25+540.1%-37.2%$31.14M$220K-1.0134News CoveragePositive NewsEarnings ReportLUNGPulmonx3.855 of 5 stars$3.10+0.3%$11.53+271.8%-75.2%$124.80M$87.47M-2.15250Trending NewsEarnings ReportAnalyst ForecastINFUInfuSystem2.8593 of 5 stars$5.91+0.2%$12.50+111.5%N/A$124.21M$137.58M98.52410BSGMBiosig Technologies2.1064 of 5 stars$4.51-1.3%$10.00+121.7%+972.2%$123.12M$40K0.0050Gap DownOBIOOrchestra BioMed2.4493 of 5 stars$3.15-7.4%$14.00+344.4%-64.4%$120.69M$2.89M-1.774News CoverageGap DownLUCDLucid Diagnostics2.7079 of 5 stars$1.09-0.5%$3.55+227.2%+25.0%$117.39M$4.35M-0.8170AVRAnteris Technologies GlobalN/A$3.22-3.9%$16.50+412.4%N/A$116.11M$2.70M0.00138ICADicad0.901 of 5 stars$3.87flatN/AN/A$106.31M$19.61M-20.37140Positive NewsZJYLJin Medical InternationalN/A$0.64-2.9%N/A-76.3%$100.51M$23.50M0.00245News CoverageGap DownFONRFonar1.266 of 5 stars$15.88-0.5%N/A-15.1%$98.43M$102.88M12.70480MBOTMicrobot Medical1.8411 of 5 stars$2.66-8.4%$9.00+239.0%+162.2%$96.59MN/A-4.0820News CoverageOptions Volume Related Companies and Tools Related Companies Pulmonx Competitors InfuSystem Competitors Biosig Technologies Competitors Orchestra BioMed Competitors Lucid Diagnostics Competitors Anteris Technologies Global Competitors icad Competitors Jin Medical International Competitors Fonar Competitors Microbot Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:COCH) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envoy Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
